(Q40434005)

English

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

scientific article

Statements

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study (English)
0 references
0 references
0 references
Franck E Nicolini
Michel Tulliez
Joelle Guilhot
Agnès Guerci-Bresler
Martine Gardembas
Valérie Coiteux
Gaelle Guillerm
Laurence Legros
Gabriel Etienne
Jean-Michel Pignon
Bruno Villemagne
Martine Escoffre-Barbe
Jean-Christophe Ianotto
Aude Charbonnier
Hyacinthe Johnson-Ansah
Marie-Pierre Noel
Philippe Rousselot
François-Xavier Mahon
France Intergroupe des Leucémies Myéloïdes Chroniques
8 December 2016
846-854

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit